Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Vivo Team

Latest From In Vivo Team

Development Versus Dealmaking: How To Obtain A Blockbuster

Most of the companies with blockbuster drugs approved over the past decade oversaw their clinical development internally. Lilly holds the lead with eight blockbusters developed in-house.

Business Strategies Companies

Execs On The Move: April 2024

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership Executive Changes

Deals Shaping The Industry, April 2024

An interactive look at pharma, medtech and diagnostics deals made during April 2024. Data courtesy of Biomedtracker.

Deals Financing

Execs On The Move: March 2024

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Medical Device BioPharmaceutical

Fujifilm Demonstrates Health Specialism With European HealthTech Spinout

From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics. 

Business Strategies Commercial

Rising Up In Biopharma: Optimism, AI And Perseverance

Ahead of In Vivo’s 2024 Rising Leaders list being revealed in April, a panel of biopharma leaders discussed industry trends and biopharma career stories at BIO-Europe Spring.

Artificial Intelligence Business Strategies
See All
UsernamePublicRestriction

Register